Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10

被引:43
作者
Chugh, Rishi Man [1 ,2 ]
Park, Hang-soo [3 ]
El Andaloussi, Abdeljabar [4 ]
Elsharoud, Amro [1 ]
Esfandyari, Sahar [1 ]
Ulin, Mara [1 ]
Bakir, Lale [5 ]
Aboalsoud, Alshimaa [5 ,6 ]
Ali, Mohamed [1 ,7 ]
Ashour, Dalia [5 ]
Igboeli, Prosper [5 ]
Ismail, Nahed [4 ]
McAllister, Jan [8 ]
Al-Hendy, Ayman [1 ,3 ,5 ]
机构
[1] Univ Illinois, Dept Surg, 820 South Wood St, Chicago, IL 60612 USA
[2] Univ Kansas, Dept Radiat Oncol, Med Ctr, Kansas City, KS 66160 USA
[3] Univ Chicago, Dept Obstet & Gynecol, 5841 S Maryland Ave, Chicago, IL 60637 USA
[4] Univ Illinois, Dept Pathol, 820 South Wood St, Chicago, IL 60612 USA
[5] Univ Illinois, Dept Obstet & Gynecol, 820 South Wood St, Chicago, IL 60612 USA
[6] Tanta Univ, Fac Med, Dept Pharmacol, Tanta, Egypt
[7] Ain Shams Univ, Fac Pharm, Clin Pharm Dept, Cairo, Egypt
[8] Penn State Hershey Coll Med, Dept Pathol, Hershey, PA USA
基金
美国国家卫生研究院;
关键词
Mesenchymal stem cells (MSCs); Cell transplantation; Cytokines; Interleukin; POLYCYSTIC-OVARY-SYNDROME; NECROSIS-FACTOR-ALPHA; GRADE CHRONIC INFLAMMATION; INSULIN-RESISTANCE; THECA CELLS; ANDROGEN PRODUCTION; ADIPOSE-TISSUE; WOMEN; BROWN; HYPERANDROGENISM;
D O I
10.1186/s13287-021-02472-w
中图分类号
Q813 [细胞工程];
学科分类号
摘要
BackgroundPolycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in reproductive-age women. Excessive inflammation and elevated androgen production from ovarian theca cells are key features of PCOS. Human bone marrow mesenchymal stem cells (BM-hMSC) and their secreted factors (secretome) exhibit robust anti-inflammatory capabilities in various biological systems. We evaluated the therapeutic efficacy of BM-hMSC and its secretome in both in vitro and in vivo PCOS models.MethodsFor in vitro experiment, we treated conditioned media from BM-hMSC to androgen-producing H293R cells and analyzed androgen-producing gene expression. For in vivo experiment, BM-hMSC were implanted into letrozole (LTZ)-induced PCOS mouse model. BM-hMSC effect in androgen-producing cells or PCOS model mice was assessed by monitoring cell proliferation (immunohistochemistry), steroidogenic gene expression (quantitative real-time polymerase chain reaction [qRT-PCR] and Western blot, animal tissue assay (H&E staining), and fertility by pup delivery.ResultsBM-hMSC significantly downregulate steroidogenic gene expression, curb inflammation, and restore fertility in treated PCOS animals. The anti-inflammatory cytokine interleukin-10 (IL-10) played a key role in mediating the effects of BM-hMSC in our PCOS models. We demonstrated that BM-hMSC treatment was improved in metabolic and reproductive markers in our PCOS model and able to restore fertility.ConclusionOur study demonstrates for the first time the efficacy of intra-ovarian injection of BM-hMSC or its secretome to treat PCOS-related phenotypes, including both metabolic and reproductive dysfunction. This approach may represent a novel therapeutic option for women with PCOS. Our results suggest that BM-hMSC can reverse PCOS-induced inflammation through IL-10 secretion. BM-hMSC might be a novel and robust therapeutic approach for PCOS treatment.
引用
收藏
页数:19
相关论文
共 74 条
  • [1] Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome
    Aytan, Asli Nehir
    Bastu, Ercan
    Demiral, Irem
    Bulut, Huri
    Dogan, Murat
    Buyru, Faruk
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (09) : 709 - 713
  • [2] Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice
    Choi, J. -J.
    Yoo, S. -A.
    Park, S. -J.
    Kang, Y. -J.
    Kim, W. -U.
    Oh, I. -H.
    Cho, C. -S.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 153 (02) : 269 - 276
  • [3] Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould, A.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (07) : 520 - 532
  • [4] Inflammation and insulin resistance
    de Luca, Carl
    Olefsky, Jerrold M.
    [J]. FEBS LETTERS, 2008, 582 (01): : 97 - 105
  • [5] Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies
    Dehkordi, Azar Nourian
    Babaheydari, Fatemeh Mirahmadi
    Chehelgerdi, Mohammad
    Dehkordi, Shiva Raeisi
    [J]. STEM CELL RESEARCH & THERAPY, 2019, 10
  • [6] Ovarian angiogenesis in polycystic ovary syndrome
    Di Pietro, Mariana
    Pascuali, Natalia
    Parborell, Fernanda
    Abramovich, Dalhia
    [J]. REPRODUCTION, 2018, 155 (05) : R199 - R209
  • [7] Metformin Regulates Ovarian Angiogenesis and Follicular Development in a Female Polycystic Ovary Syndrome Rat Model
    Di Pietro, Mariana
    Parborell, Fernanda
    Irusta, Griselda
    Pascuali, Natalia
    Bas, Diana
    Silvia Bianchi, Mara
    Tesone, Marta
    Abramovich, Dalhia
    [J]. ENDOCRINOLOGY, 2015, 156 (04) : 1453 - 1463
  • [8] Cancer risk and PCOS
    Dumesic, Daniel A.
    Lobo, Rogerio A.
    [J]. STEROIDS, 2013, 78 (08) : 782 - 785
  • [9] Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
    Eggenhofer, E.
    Benseler, V.
    Kroemer, A.
    Popp, F. C.
    Geissler, E. K.
    Schlitt, H. J.
    Baan, C. C.
    Dahlke, M. H.
    Hoogduijn, M. J.
    [J]. FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [10] Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility
    Esfandyari, Sahar
    Chugh, Rishi Man
    Park, Hang-soo
    Hobeika, Elie
    Ulin, Mara
    Al-Hendy, Ayman
    [J]. CELLS, 2020, 9 (10) : 1 - 19